NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 89 filers reported holding NOVOCURE LTD in Q2 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $512,000 | -18.2% | 7,610 | +2.5% | 0.03% | +3.6% |
| Q4 2019 | $626,000 | +15.9% | 7,423 | +2.8% | 0.03% | +12.0% |
| Q3 2019 | $540,000 | +18.2% | 7,224 | -0.1% | 0.02% | +19.0% |
| Q2 2019 | $457,000 | +57.0% | 7,234 | +19.9% | 0.02% | +50.0% |
| Q1 2019 | $291,000 | +44.1% | 6,033 | 0.0% | 0.01% | +27.3% |
| Q4 2018 | $202,000 | -36.1% | 6,033 | 0.0% | 0.01% | -26.7% |
| Q3 2018 | $316,000 | +67.2% | 6,033 | 0.0% | 0.02% | +66.7% |
| Q2 2018 | $189,000 | +70.3% | 6,033 | +19.0% | 0.01% | +80.0% |
| Q1 2018 | $111,000 | +8.8% | 5,070 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $102,000 | -1.0% | 5,070 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $103,000 | +17.0% | 5,070 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $88,000 | +175.0% | 5,070 | +28.5% | 0.00% | +100.0% |
| Q1 2017 | $32,000 | – | 3,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |